NCT00336063 2026-03-18Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell LymphomaNational Cancer Institute (NCI)Phase 1 Active not recruiting18 enrolled